Mumbai: With sales of weight-loss drugs surging and set to go up even more as semaglutide goes off patent early next year, a low-profile manufacturer of injector pens, Gujarat-based Shaily Engineering ...

SAO PAULO, May 26 (Reuters) - Brazil's health regulator Anvisa said on Tuesday it ‌had approved EMS's Ozivy, the country's first ‌semaglutide-based injector pen, as the drugmaker looks to expand into ...

Ozempic and Mounjaro have transformed the market for diabetes and weight-management medications, generating enormous business ...

Unlike current treatment options, which often require patients to purchase multiple single-dose pens as they progressively titrate their dosage, Zydus offers an ...

HYDERABAD, India & MISSISSAUGA, Ontario, May 16, 2026--(BUSINESS WIRE)--Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along ...

Lupin will gain semi-exclusive co-marketing rights for Zydus’ semaglutide injection in India under Semanext and Livarise, while Zydus retains its brands Semaglyn, Mashema and Alterme. Managing ...

The Food and Drug Administration is now investigating an array of fraudulent schemes that appear to be trafficking counterfeit versions of Ozempic, an industry trade group recently warned its members.

You're currently following this author! Click to unsubscribe from email alerts. A new pill version of semaglutide for weight loss could soon be coming to a pharmacy ...

Major insurers are split over a Medicare plan to bar vendor-run remote monitoring. What it may mean for Medicare Advantage members before open enrollment. Nursing Home Capacity Fell 5% from 2019 to ...

Researchers discovered semaglutide—the active ingredient in Ozempic and Wegovy—may reduce the risk of death and lower the chance of developing cardiovascular conditions like stroke and heart attack in ...